Chargement en cours...
Medical Treatment of Benign Prostatic Hyperplasia
Medical therapy for the treatment of benign prostatic hyperplasia (BPH) became an accepted standard of care in the 1990s following the reports of randomized, double-blind, placebo-controlled studies showing that finasteride, a 5-α reductase inhibitor, and terazosin, an α-blocker, significantly impro...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MedReviews, LLC
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3151584/ https://ncbi.nlm.nih.gov/pubmed/21826125 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|